Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Labcorp Holdings Inc.(LH US)

$369.83-2.490.67%(Market Open · 19:47:28 UTC)
ProfileFinancialsChartingShort InterestEmployees

Overview

Profile

Financials & Metrics

FinancialsChartingShort InterestEmployees
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Labcorp Holdings Inc.(LH US)

$369.83-2.490.67%(Market Open · 19:47:28 UTC)
ProfileFinancialsChartingShort InterestEmployees

Overview

Profile

Financials & Metrics

FinancialsChartingShort InterestEmployees
LH US​
Ask AI

Labcorp Holdings Inc. — Company Profile

Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.

Sector
Health Care
Industry
Health Care Equipment & Supplies
Exchange
UN
CEO
Adam H. Schechter
Headquarters
Burlington, NC, US
IPO Date
Mar 29, 1990
Employees
71,000
Website
www.labcorp.com

Key Metrics

Price
$308.49
Market Cap
$25.30B
Revenue (TTM)
$3.54B
Net Income (TTM)
$277.80M
EPS (TTM)
3.37
P/E (TTM)
26.87
P/B (TTM)
2.90
Dividend Yield
110.74%
ROE (TTM)
3.18%
ROA (TTM)
1.46%
Operating Margin
10.95%
Beta
0.21

Dividends

Last Dividend
$0.72
Last Yield
1.11%

Summary

Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.

Website
www.labcorp.com
Location
Burlington, NC, US
Phone336 229 1127
Employees71,000
CEOAdam H. Schechter
Sector
Health Care
Industry
Health Care Equipment & Supplies
IPO DateMar 29, 1990

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

News

  • Labcorp's Lab Growth Surges as $125 Million Reimbursement Risk Looms11:15AM
  • Labcorp: 3 Key Takeaways for Long-Term Investors12 Nov
  • Labcorp Holdings Inc. (LH) Presents at 2026 UBS Global Healthcare Conference Transcript11 Nov
  • Is Now the Right Time to Hold Labcorp Stock in Your Portfolio?10 Nov
  • Labcorp (NYSE:LH) Hits New 52-Week High on Analyst Upgrade6 Nov
  • Labcorp Holdings (LH) is a Top-Ranked Momentum Stock: Should You Buy?5 Nov
  • Buy, Sell, or Hold? Thursday’s Top Upgrades and Downgrades: Block, Cisco Systems, Dollar Tree, First Solar, HubSpot, JetBlue Airways, Nike, Space-X, Skyworks Solutions, and More5 Nov
  • Labcorp to Speak at the UBS Global Healthcare Conference4 Nov
  • Labcorp Holdings (LH) is a Top-Ranked Value Stock: Should You Buy?30 Oct
  • Labcorp Q3 Earnings Call Highlights30 Oct
  • Labcorp Holdings: The Optimism May Be Going Overboard (Rating Downgrade)29 Oct
  • Labcorp Holdings Inc. (LH) Q3 2026 Earnings Call Transcript28 Oct
  • Labcorp Targets Margin Growth, Absorbs Policy Headwinds28 Oct
  • Labcorp Q3 Earnings Call Highlights28 Oct
  • LH Stock Rises on Q3 Earnings and Revenue Beat, '26 View Up28 Oct
  • Compared to Estimates, Labcorp (LH) Q3 Earnings: A Look at Key Metrics28 Oct
  • Labcorp Holdings (LH) Q3 Earnings and Revenues Surpass Estimates28 Oct
  • Labcorp Reports Strong 2026 Third Quarter Results; Raises Full Year 2026 Guidance28 Oct
  • Waters & Labcorp Expand Access to FDA-Approved HPV Screening Tests27 Oct
  • Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 202623 Oct

Key Stats

Trading

Px/Chg 1D$308.49 / +1.28%
Avg Volume630.24K
Beta0.21
Mkt Cap25.30B
FD Mkt Cap27.44B

Float

Shrs Out/Float82.00M / 81.67M
Short Float0.03%
Days to Cover3.80
Stock Repurchased$98.00M

Current Valuation

EV31.57B
EV/EBITDA15.31
EV/Sales2.23
P/B2.90
P/S1.79
FCF Yield0.28%
ROE3.18%
ROA1.46%
Current Ratio1.73

Dividend

Cash$0.72
Yield110.74%
Yield (TTM)110.74%

Estimates

P/E26.87
Est P/E0.00
Est EPS4.11
Est PEG0.00

Valuation

Metric5Yr AvgMay '23Apr '24Apr '25May '26Oct '26
PRICE-BASED RATIOS
Price / Earnings60.2813.8342.5425.82128.1591.06
Price / Sales3.521.491.461.486.007.15
Price / Book Value2.351.752.262.392.452.90
Price / Free Cash Flow90.3612.0020.3417.5843.05358.81
ENTERPRISE VALUE METRICS
Enterprise Value26,250.323,630.923,216.125,031.827,800.031,572.6
Enterprise Value / Sales4.531.991.911.927.918.92
Enterprise Value / EBITDA33.4312.0917.2013.8266.4157.60
Enterprise Value / EBIT53.1516.6730.2121.44113.1984.24

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue1.5%13,136.111,863.912,161.613,008.913,951.7
Gross Income-7%4,992.43,708.93,364.93,624.43,732.5
EBITDA-14%3,676.41,954.41,349.41,811.32,012.7
EBIT-19%3,099.41,417.2768.51,167.81,331.6
Net Income-22.1%2,377.31,279.1418.0746.0876.5
EPS (Diluted)-19.1%24.3813.964.778.8410.46
BALANCE SHEET
Cash & ST Inv-22.5%1,472.7320.6536.81,518.7532.3
Total Assets-2.5%20,385.420,155.116,725.118,379.018,392.7
Total Liabilities-84.1%10,091.410,039.68,834.610,312.59,756.0
Total Shareholder Equity-4.3%10,273.410,096.67,875.08,052.28,619.8
CASH FLOW
Net Operating Cash Flow-14.8%3,109.61,955.91,327.71,585.81,640.5
Cap Ex-1.4%-460.4-481.9-453.6-489.9-434.5
Free Cash Flow-17.9%2,649.21,474.0874.11,095.91,206.0

Enterprise Value Bridge

Millions USD13 Nov '26
Price (As of 13 Nov '26)369.84
Basic Shares82.00
Market Cap30,326.9
Diluted Shares81.60
Fully Diluted Shares Outstanding81.60
Fully Diluted Market Cap30,178.9
+Consolidated Debt6,775.9
−In-the-Money Convertible Debt—
+Capital Leases924.0
+Operating Leases—
−Cash & Equivalents-261.8
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest16.1
+Pension Liabilities—
Enterprise Value36,857.1

Segment data

Revenue

by Products and services

  • Labcorp Diagnostics100%

Revenue

by Geography

  • North America81%
  • Europe13%
  • Other Countries6%

Related companies

WuXi AppTec Co., Ltd.

WUXAY US

Natera, Inc.

NTRA US

Guardant Health, Inc.

GH US

WuXi XDC Cayman Inc

2268 HK

Caris Life Sciences, Inc.

CAI US

Sonic Healthcare Ltd / ADR

SKHHY US

GRAIL, Inc.

GRAL US

Joinn Laboratories(China)Co.,Ltd.

603127 CG

RadNet, Inc.

RDNT US

Sotera Health Co

SHC US

Vontier Corp

VNT US

DiaSorin S.p.A.

DSRLF US

LH US​
Ask AI

Labcorp Holdings Inc. — Company Profile

Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.

Sector
Health Care
Industry
Health Care Equipment & Supplies
Exchange
UN
CEO
Adam H. Schechter
Headquarters
Burlington, NC, US
IPO Date
Mar 29, 1990
Employees
71,000
Website
www.labcorp.com

Key Metrics

Price
$308.49
Market Cap
$25.30B
Revenue (TTM)
$3.54B
Net Income (TTM)
$277.80M
EPS (TTM)
3.37
P/E (TTM)
26.87
P/B (TTM)
2.90
Dividend Yield
110.74%
ROE (TTM)
3.18%
ROA (TTM)
1.46%
Operating Margin
10.95%
Beta
0.21

Dividends

Last Dividend
$0.72
Last Yield
1.11%

Summary

Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.

Website
www.labcorp.com
Location
Burlington, NC, US
Phone336 229 1127
Employees71,000
CEOAdam H. Schechter
Sector
Health Care
Industry
Health Care Equipment & Supplies
IPO DateMar 29, 1990

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

News

  • Labcorp's Lab Growth Surges as $125 Million Reimbursement Risk Looms11:15AM
  • Labcorp: 3 Key Takeaways for Long-Term Investors12 Nov
  • Labcorp Holdings Inc. (LH) Presents at 2026 UBS Global Healthcare Conference Transcript11 Nov
  • Is Now the Right Time to Hold Labcorp Stock in Your Portfolio?10 Nov
  • Labcorp (NYSE:LH) Hits New 52-Week High on Analyst Upgrade6 Nov
  • Labcorp Holdings (LH) is a Top-Ranked Momentum Stock: Should You Buy?5 Nov
  • Buy, Sell, or Hold? Thursday’s Top Upgrades and Downgrades: Block, Cisco Systems, Dollar Tree, First Solar, HubSpot, JetBlue Airways, Nike, Space-X, Skyworks Solutions, and More5 Nov
  • Labcorp to Speak at the UBS Global Healthcare Conference4 Nov
  • Labcorp Holdings (LH) is a Top-Ranked Value Stock: Should You Buy?30 Oct
  • Labcorp Q3 Earnings Call Highlights30 Oct
  • Labcorp Holdings: The Optimism May Be Going Overboard (Rating Downgrade)29 Oct
  • Labcorp Holdings Inc. (LH) Q3 2026 Earnings Call Transcript28 Oct
  • Labcorp Targets Margin Growth, Absorbs Policy Headwinds28 Oct
  • Labcorp Q3 Earnings Call Highlights28 Oct
  • LH Stock Rises on Q3 Earnings and Revenue Beat, '26 View Up28 Oct
  • Compared to Estimates, Labcorp (LH) Q3 Earnings: A Look at Key Metrics28 Oct
  • Labcorp Holdings (LH) Q3 Earnings and Revenues Surpass Estimates28 Oct
  • Labcorp Reports Strong 2026 Third Quarter Results; Raises Full Year 2026 Guidance28 Oct
  • Waters & Labcorp Expand Access to FDA-Approved HPV Screening Tests27 Oct
  • Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 202623 Oct

Key Stats

Trading

Px/Chg 1D$308.49 / +1.28%
Avg Volume630.24K
Beta0.21
Mkt Cap25.30B
FD Mkt Cap27.44B

Float

Shrs Out/Float82.00M / 81.67M
Short Float0.03%
Days to Cover3.80
Stock Repurchased$98.00M

Current Valuation

EV31.57B
EV/EBITDA15.31
EV/Sales2.23
P/B2.90
P/S1.79
FCF Yield0.28%
ROE3.18%
ROA1.46%
Current Ratio1.73

Dividend

Cash$0.72
Yield110.74%
Yield (TTM)110.74%

Estimates

P/E26.87
Est P/E0.00
Est EPS4.11
Est PEG0.00

Valuation

Metric5Yr AvgMay '23Apr '24Apr '25May '26Oct '26
PRICE-BASED RATIOS
Price / Earnings60.2813.8342.5425.82128.1591.06
Price / Sales3.521.491.461.486.007.15
Price / Book Value2.351.752.262.392.452.90
Price / Free Cash Flow90.3612.0020.3417.5843.05358.81
ENTERPRISE VALUE METRICS
Enterprise Value26,250.323,630.923,216.125,031.827,800.031,572.6
Enterprise Value / Sales4.531.991.911.927.918.92
Enterprise Value / EBITDA33.4312.0917.2013.8266.4157.60
Enterprise Value / EBIT53.1516.6730.2121.44113.1984.24

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue1.5%13,136.111,863.912,161.613,008.913,951.7
Gross Income-7%4,992.43,708.93,364.93,624.43,732.5
EBITDA-14%3,676.41,954.41,349.41,811.32,012.7
EBIT-19%3,099.41,417.2768.51,167.81,331.6
Net Income-22.1%2,377.31,279.1418.0746.0876.5
EPS (Diluted)-19.1%24.3813.964.778.8410.46
BALANCE SHEET
Cash & ST Inv-22.5%1,472.7320.6536.81,518.7532.3
Total Assets-2.5%20,385.420,155.116,725.118,379.018,392.7
Total Liabilities-84.1%10,091.410,039.68,834.610,312.59,756.0
Total Shareholder Equity-4.3%10,273.410,096.67,875.08,052.28,619.8
CASH FLOW
Net Operating Cash Flow-14.8%3,109.61,955.91,327.71,585.81,640.5
Cap Ex-1.4%-460.4-481.9-453.6-489.9-434.5
Free Cash Flow-17.9%2,649.21,474.0874.11,095.91,206.0

Enterprise Value Bridge

Millions USD13 Nov '26
Price (As of 13 Nov '26)369.84
Basic Shares82.00
Market Cap30,326.9
Diluted Shares81.60
Fully Diluted Shares Outstanding81.60
Fully Diluted Market Cap30,178.9
+Consolidated Debt6,775.9
−In-the-Money Convertible Debt—
+Capital Leases924.0
+Operating Leases—
−Cash & Equivalents-261.8
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest16.1
+Pension Liabilities—
Enterprise Value36,857.1

Segment data

Revenue

by Products and services

  • Labcorp Diagnostics100%

Revenue

by Geography

  • North America81%
  • Europe13%
  • Other Countries6%

Related companies

WuXi AppTec Co., Ltd.

WUXAY US

Natera, Inc.

NTRA US

Guardant Health, Inc.

GH US

WuXi XDC Cayman Inc

2268 HK

Caris Life Sciences, Inc.

CAI US

Sonic Healthcare Ltd / ADR

SKHHY US

GRAIL, Inc.

GRAL US

Joinn Laboratories(China)Co.,Ltd.

603127 CG

RadNet, Inc.

RDNT US

Sotera Health Co

SHC US

Vontier Corp

VNT US

DiaSorin S.p.A.

DSRLF US